GLP-1RA-mediated IL-4 release from eosinophils indicated above may alter the beneficial effects of eosinophils as strategies are being developed to target obesity through eosinophils and sympathetic fat [197]. The gene discussed is IL4; the disease is obesity due to melanocortin 4 receptor deficiency.